Gland Pharma Q3: Strong and clean play on global generic injectables; accumulate

Trading Calls - Equity F&O

We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers

Anubhav Sahu